CĂRȚI ÎN ROMÂNĂ ÎN LEGĂTURĂ CU «OCUL»
Descoperă întrebuințarea
ocul în următoarea selecție bibliografică. Cărți în legătură cu
ocul și extrase din aceasta pentru a furniza contextul de întrebuințare al acestuia în literatura Română.
1
Perimetry Update 1994/1995: Proceedings of the XIth ... - Pagina 199
Boll Ocul 70:297, 1991 Boles Carenini A, Valvo G, Sibour G. Meccanismo d'azione dell'ibopamina: studio emodinamico. Atti del LXXII Congr. S.O.I. 413–417, 1992 . Casagrande C, Ghirardi P, Marchetti G: Ibopamine. In: Scriabine A (ed) New ...
Richard P. Mills, Michael Wall, 1995
2
Ultrasonography in Ophthalmology XV
V. Mazzeo. Ecografia dell'apparato oculare. TestoAtlante. Milano: Fogliazza Ed. 1987. V. Mazzeo, P. Perri, L. Ravalli, R. Monari and M. Chiarelli. Angioma cavernoso della coroide: nostra esperienza. Clin. Ocul. e Patol. Ocul. 1992;4:220–222.
Giovanni Cennamo, N. Rosa, 1997
3
E-Journals Access and Management - Pagina 107
business: at present, no detailed exit strategy from large consortium deals has been formulated by OCUL. This could be of concern if some critical level of participation were lost midway through a license subscription and no successful ...
4
The Glaucomas: Volume II - Open Angle Glaucoma and Angle ...
Boll Ocul 65:1135–1146 Virno M, Pecori Giraldi J, Taverniti L et al (1987) Effetti ipertensivi oculari dell'ibopamine somministrata per via locale in soggetti con turbe idrodinamiche endoculari (Nuovo test di provocazione). Boll Ocul ...
Roberto Sampaolesi, Juan Roberto Sampaolesi, Jorge Zárate, 2013
5
Intravitreal Steroids - Pagina 90
Ocul Immunol Inflamm. 2009;17:423–30. Soheilian M, Rabbanikhah Z, Ramezani A, Kiavash V, Yaseri M, Peyman GA. Intravitreal bevacizumab versus triamcinolone acetonide for refractory uveitic cystoid macular edema: a randomized pilot ...
6
Atlas and Text of Corneal Pathology and Surgery - Pagina 79
Arch Ophthalmol 2001;119:1439-52 4. Chen Y, Mehta G, Vasiliou V. Antioxidant defenses in the ocular surface. Ocul Surf 2009;7:176-85 5. Sullivan DA. Tearful relationship.7 Sex, hormones, the lacrimal gland, and aqueous-deficient dry eye, ...
Boyd Samuel, Gutierrez Angela Maria, McCulley James P., 2011
7
Master Techniques in Ophthalmic Surgery - Pagina 599
2012;2(1):13-9. Epub 2011 Oct 16. Paroli MP, Spinucci G, Monte R, Pesci FR, Abicca I, Pivetti Pezzi P. Intermediate uveitis in a pediatric Italian population. Ocul Immunol Inflamm. 2011, 19(5):321-6. Grégoire MA, Kodjikian L, Varron L, Grange ...
Frederick Hampton Roy, 2015
8
A Latin Grammar for the Use of English Boys: Being an ... - Pagina 14
SECOND DECLENSION. Singular. Nom. Gen. Dat. Acc. Voc. Abl. Oculus Ocul i Ocul o Ocul um Ocul e Ocul o an Eye of an Eye to an Eye an Eye O Eye from an Eya Norm Gen. Dat. Acc. Voc. Abl. Plural. Oculi Ocul orum 14 [Chap. ETYMOIOGY.
9
Ocular Transporters and Receptors: Their Role in Drug Delivery
(2011) Ocular sustained release nanoparticles containing stereoisomeric dipeptide prodrugs of acyclovir. J. Ocul. Pharmacol. Ther., 27(2): 163–72. Atluri, H., et al. (2004) Mechanism of a model dipeptide transport across blood-ocular barriers ...
10
The London encyclopaedia, or, Universal dictionary of ... - Pagina 204
Pterygoidei externi. Pterygoidei interni. Pterygo-pharyngei. Circumftexi palati. Externi malleorum Levatores palpeb. super. Obliqui super, ocul. □ Recti attollentes ocul. Recti abductores ocul. Recti adductores ocul. Recti depressores ocul. VIII.
Thomas Curtis (of Grove house sch, Islington), 1839
ȘTIRI NOI CARE INCLUD TERMENUL «OCUL»
Află ce ziare naționale și internaționale au scris despre și cum este întrebuințat termenul
ocul în contextul următoarelor știri.
Company Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) Rally …
Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) appreciated by 20.2% during the past week but lost 41.29% on a 4-week basis. The shares have ... «Insider Trading Report, Nov 15»
Ocular Therapeutix (OCUL) Enters Oversold Territory
Ocular Therapeutix Inc (OCUL - Snapshot Report) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked ... «Zacks.com, Oct 15»
Ocular Therapeutix Raised to Buy at Zacks (OCUL)
Ocular Therapeutix logo Ocular Therapeutix (NASDAQ:OCUL) was upgraded by Zacks from a “hold” rating to a “buy” rating in a report issued on Tuesday, ... «Dakota Financial News, Oct 15»
Company Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL …
Ocular Therapeutix, Inc. (NASDAQ:OCUL) has lost 55.95% during the past week and dropped 53.47% in the last 4 weeks. The shares are however, negative as ... «Insider Trading Report, Oct 15»
Health Care Sector Update for 10/23/2015: OCUL,IG,MMSI
OCUL shares were down almost 53% this afternoon at $7.14 each, earlier falling to a worst-ever $6.75 a share. In other sector news,. (+) IG, Reports Q3 ... «Nasdaq, Oct 15»
Unusual 11 Mid-Day Movers 10/23: (HZNP) (NTGR) (IG) Higher …
Ocular Therapeutix, Inc. (Nasdaq: OCUL) 51.9% LOWER; announced topline results through 90 days of therapy from its Phase 2b clinical trial of OTX-TP ... «StreetInsider.com, Oct 15»
Ocular Therapeutix (OCUL) Announces Statistically Significant …
Ocular Therapeutix (NASDAQ: OCUL) announced topline efficacy results from a Phase 3 clinical trial to evaluate the safety and efficacy of DEXTENZA™ ... «StreetInsider.com, Oct 15»
FDA Snubs SPPI, OCUL Feels Pressure, It's Thumbs Up For MACK …
OCUL closed Thursday's trading at $15.06, down 1.70%. In after hours, the stock fell 7.04% to $14.00. Spectrum Pharmaceuticals (SPPI) has been issued a ... «Nasdaq, Oct 15»
Ocular (OCUL) Initiates Third Phase III Study on Dextenza
Ocular Therapeutix, Inc. (OCUL - Snapshot Report) announced the initiation of patient enrolment in the third phase III study on Dextenza (sustained release ... «Zacks.com, Oct 15»
Watch List: Cara Therapeutics (NASDAQ:CARA), Ocular …
On 16 October, Ocular Therapeutix, Inc. (NASDAQ:OCUL) has enrolled the first patients in its third phase 3 clinical trial for Dextenza to treat postoperative ocular ... «Benchmark Monitor, Oct 15»
